Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06139627 · ClinicalTrials.gov registry record · NA
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy
A NA study of Lung Non-Small Cell Carcinoma and Stage III Lung Cancer AJCC v8, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 3
- Study locations
NCT06139627 is a NA study of Lung Non-Small Cell Carcinoma and Stage III Lung Cancer AJCC v8 that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 180 participants, above the 156-participant average among 47 other Lung Non-Small Cell Carcinoma trials with a reported enrollment target (15% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT06139627, a NA study of Lung Non-Small Cell Carcinoma and Stage III Lung Cancer AJCC v8, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial tests how well a geriatric assessment (GA) with GA-directed treatment recommendations, compared to GA with usual care, works in identifying risk factors, reducing chemotherapy radiation toxicity and functional decline, and improving the overall quality of life in older patients with non-small cell lung cancer (NSCLC). Older patients with lung cancer undergoing chemotherapy are at an increased risk of adverse outcomes including treatment toxicity and functional and physical consequences. This makes it very challenging for the physicians to balance the benefits against the risk of chemotherapy in older cancer patients. A geriatric assessment may be useful in identifying risk factors for chemotherapy radiation toxicity. Communicating these geriatric assessment findings and assessment-based recommendations to a patient's treating physicians may help them make more informed decisions about treatment options for patients. Making treatment decisions using GA-based recommendations may reduce adverse events and improve outcomes in patients receiving treatment for NSCLC.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Best Practice
- OTHER Communication Intervention
- OTHER Comprehensive Geriatric Assessment
- OTHER Electronic Health Record Review
Study Locations (3)
California
- City of Hope Medical Center - Duarte
New York
- University of Rochester - Rochester
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-05-21 |
| Est. Completion | 2026-07-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06139627
The ClinicalTrials.gov registry entry for NCT06139627 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 156-participant average among 47 other Lung Non-Small Cell Carcinoma trials with a reported enrollment target (15% higher). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lung Non-Small Cell Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.
NCT06139627 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT06139627 about?
NCT06139627 is a clinical study titled "Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy". This clinical trial tests how well a geriatric assessment (GA) with GA-directed treatment recommendations, compared to GA with usual care, works in identifying risk factors, reducing chemotherapy radiation toxicity and functional decline, and improving the overall quality of life in older patients w...
What is the current status of trial NCT06139627?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-05-21. Estimated completion is 2026-07-19.
What conditions does trial NCT06139627 study?
This clinical trial studies the following conditions: Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8.
What interventions are being tested in trial NCT06139627?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Best Practice (OTHER), Communication Intervention (OTHER), Comprehensive Geriatric Assessment (OTHER), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT06139627?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06139627 being conducted?
This trial has 3 study locations across California, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Non-Small Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
RECRUITING · NA
-
The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer
RECRUITING · NA
-
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
RECRUITING · NA
-
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
RECRUITING · NA
-
Exercise Training for the Improvement of Immune Activity and Treatment Outcomes During Immunotherapy for Non-small Cell Lung Cancer, BOOST Trial
RECRUITING · NA
-
Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer
RECRUITING · NA
Explore more on PlainTrial
Lung Non-Small Cell Carcinoma
All registered trials for this condition
Stage III Lung Cancer AJCC v8
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.